200 related articles for article (PubMed ID: 29997781)
1. Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action.
Raveendran R; Braude JP; Wexselblatt E; Novohradsky V; Stuchlikova O; Brabec V; Gandin V; Gibson D
Chem Sci; 2016 Mar; 7(3):2381-2391. PubMed ID: 29997781
[TBL] [Abstract][Full Text] [Related]
2. Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance.
Petruzzella E; Sirota R; Solazzo I; Gandin V; Gibson D
Chem Sci; 2018 May; 9(18):4299-4307. PubMed ID: 29780561
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates.
Novohradsky V; Zanellato I; Marzano C; Pracharova J; Kasparkova J; Gibson D; Gandin V; Osella D; Brabec V
Sci Rep; 2017 Jun; 7(1):3751. PubMed ID: 28623355
[TBL] [Abstract][Full Text] [Related]
4. Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells.
Almotairy ARZ; Montagner D; Morrison L; Devereux M; Howe O; Erxleben A
J Inorg Biochem; 2020 Sep; 210():111125. PubMed ID: 32521289
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of cis-Diamminediacetato Pt
Khattib D; Ishan M; Karmakar S; Kostrhunova H; Brabec V; Gibson D
Chemistry; 2020 Aug; 26(43):9475-9480. PubMed ID: 32428256
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Cytotoxicity of Water-Soluble Dual- and Triple-Action Satraplatin Derivatives: Replacement of Equatorial Chlorides of Satraplatin by Acetates.
Karmakar S; Poetsch I; Kowol CR; Heffeter P; Gibson D
Inorg Chem; 2019 Dec; 58(24):16676-16688. PubMed ID: 31790216
[TBL] [Abstract][Full Text] [Related]
7. ctc-[Pt(NH
Li Y; Shi S; Zhang S; Gan Z; Wang X; Zhao X; Zhu Y; Cao M; Wang X; Li W
Dalton Trans; 2021 Aug; 50(32):11180-11188. PubMed ID: 34338267
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
9. Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects.
Tabrizi L; Thompson K; Mnich K; Chintha C; Gorman AM; Morrison L; Luessing J; Lowndes NF; Dockery P; Samali A; Erxleben A
Mol Pharm; 2020 Aug; 17(8):3009-3023. PubMed ID: 32628022
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and valproate released from the bifunctional [Pt
Ravera M; Gabano E; Zanellato I; Gallina A; Perin E; Arrais A; Cantamessa S; Osella D
Dalton Trans; 2017 Jan; 46(5):1559-1566. PubMed ID: 28091654
[TBL] [Abstract][Full Text] [Related]
11. New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.
Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
Biochem Pharmacol; 2015 Jun; 95(3):133-44. PubMed ID: 25888926
[TBL] [Abstract][Full Text] [Related]
12. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
Pang SK; So WK; Ho YP; Au-Yeung CF
Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
[TBL] [Abstract][Full Text] [Related]
13. Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)].
Brabec V; Griffith DM; Kisova A; Kostrhunova H; Zerzankova L; Marmion CJ; Kasparkova J
Mol Pharm; 2012 Jul; 9(7):1990-9. PubMed ID: 22591133
[TBL] [Abstract][Full Text] [Related]
14. DNA-platinum interactions in vitro with trans- and cis-Pt(NH3)2Cl2.
Macquet JP; Theophanides T
Bioinorg Chem; 1975; 5(1):59-66. PubMed ID: 1182209
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin.
Zajac J; Kostrhunova H; Novohradsky V; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2016 Mar; 156():89-97. PubMed ID: 26780576
[TBL] [Abstract][Full Text] [Related]
16. Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.
Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2014 Nov; 140():72-9. PubMed ID: 25063910
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position.
Tolan D; Gandin V; Morrison L; El-Nahas A; Marzano C; Montagner D; Erxleben A
Sci Rep; 2016 Jul; 6():29367. PubMed ID: 27404565
[TBL] [Abstract][Full Text] [Related]
19. Similar binding of the carcinostatic drugs cis-[Pt(NH3)2Cl2] and [Ru(NH3)5Cl] Cl2 to tRNAphe and a comparison with the binding of the inactive trans-[Pt(NH3)2Cl2] complex - reluctance in binding to Watson-Crick base pairs within double helix.
Rubin JR; Sabat M; Sundaralingam M
Nucleic Acids Res; 1983 Sep; 11(18):6571-86. PubMed ID: 6353373
[TBL] [Abstract][Full Text] [Related]
20. cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells.
Salles B; Butour JL; Lesca C; Macquet JP
Biochem Biophys Res Commun; 1983 Apr; 112(2):555-63. PubMed ID: 6682656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
